Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 714

Similar articles for PubMed (Select 19336547)

1.

Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.

Hsu WL, Chen JY, Chien YC, Liu MY, You SL, Hsu MM, Yang CS, Chen CJ.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1218-26. doi: 10.1158/1055-9965.EPI-08-1175. Epub 2009 Mar 31.

2.

Quantification of EBV DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern china.

Zheng XH, Lu LX, Li XZ, Jia WH.

Cancer Sci. 2015 Jun 17. doi: 10.1111/cas.12718. [Epub ahead of print]

PMID:
26082292
3.

(P089) p16 as a Complementary Prognostic Marker for EBV-Positive Nasopharyngeal Carcinoma.

[No authors listed]

Oncology (Williston Park). 2015 Apr 21;29(4 Suppl 1). pii: 205151. No abstract available.

4.

Tobacco smoking, family history, and the risk of nasopharyngeal carcinoma: a case-referent study in Hong Kong Chinese.

Xie SH, Yu IT, Tse LA, Au JS, Lau JS.

Cancer Causes Control. 2015 Jun;26(6):913-21. doi: 10.1007/s10552-015-0572-x. Epub 2015 Mar 31.

PMID:
25822573
5.

Cigarette smoking and the antibody response to inhaled antigens.

McSharryy C, Wilkinson PC.

Immunol Today. 1986 Apr;7(4):97-8. doi: 10.1016/0167-5699(86)90145-3. No abstract available.

PMID:
25289796
6.

ABO blood group, Epstein-Barr virus infection and prognosis of patients with non-metastatic nasopharyngeal carcinoma.

Zhang YX, Kang SY, Chen G, Fang WF, Wu X, You HJ, He DC, Cao YL, Liang WH, Zhang L.

Asian Pac J Cancer Prev. 2014;15(17):7459-65.

7.

Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature.

Coghill AE, Hildesheim A.

Am J Epidemiol. 2014 Oct 1;180(7):687-95. doi: 10.1093/aje/kwu176. Epub 2014 Aug 28. Review.

PMID:
25167864
8.

Association of Epstein-Barr virus and passive smoking with the risk of breast cancer among Chinese women.

Qi ML, Xi J, Chen LJ, Su Y, Cen YL, Su FX, Lin Y, Zhuang ZX, Tang LY, Ren ZF.

Eur J Cancer Prev. 2014 Sep;23(5):405-11. doi: 10.1097/CEJ.0000000000000071.

PMID:
25010836
9.

Lifetime risk of distinct upper aerodigestive tract cancers and consumption of alcohol, betel and cigarette.

Hsu WL, Chien YC, Chiang CJ, Yang HI, Lou PJ, Wang CP, Yu KJ, You SL, Wang LY, Chen SY, Yang CS, Chen CJ.

Int J Cancer. 2014 Sep 15;135(6):1480-6. doi: 10.1002/ijc.28791. Epub 2014 Mar 3.

PMID:
24535776
10.

Prognostic impact of cigarette smoking on the survival of patients with established nasopharyngeal carcinoma.

Ouyang PY, Su Z, Mao YP, Liang XX, Liu Q, Deng W, Xie FY.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2285-94. doi: 10.1158/1055-9965.EPI-13-0546. Epub 2013 Nov 19.

11.

Mortality in schizophrenia: clinical and serological predictors.

Dickerson F, Stallings C, Origoni A, Schroeder J, Khushalani S, Yolken R.

Schizophr Bull. 2014 Jul;40(4):796-803. doi: 10.1093/schbul/sbt113. Epub 2013 Aug 13.

12.

Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer.

Camargo MC, Koriyama C, Matsuo K, Kim WH, Herrera-Goepfert R, Liao LM; Eurgast-EPIC Group, Yu J, Carrasquilla G, Sung JJ, Alvarado-Cabrero I, Lissowska J, Meneses-Gonzalez F, Yatabe Y, Ding T, Hu N, Taylor PR, Morgan DR, Gulley ML, Torres J, Akiba S, Rabkin CS.

Int J Cancer. 2014 Feb 15;134(4):948-53. doi: 10.1002/ijc.28402. Epub 2013 Aug 28.

13.

EBV and nasopharyngeal carcinoma: a target for cellular therapies.

Smith C.

Immunotherapy. 2013 Aug;5(8):821-4. doi: 10.2217/imt.13.68.

PMID:
23902550
14.

Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).

Kamper-Jørgensen M, Rostgaard K, Glaser SL, Zahm SH, Cozen W, Smedby KE, Sanjosé S, Chang ET, Zheng T, La Vecchia C, Serraino D, Monnereau A, Kane EV, Miligi L, Vineis P, Spinelli JJ, McLaughlin JR, Pahwa P, Dosman JA, Vornanen M, Foretova L, Maynadie M, Staines A, Becker N, Nieters A, Brennan P, Boffetta P, Cocco P, Hjalgrim H.

Ann Oncol. 2013 Sep;24(9):2245-55. doi: 10.1093/annonc/mdt218. Epub 2013 Jun 19. Review.

15.

Risk of developing sudden sensorineural hearing loss in patients with nasopharyngeal carcinoma: a population-based cohort study.

Lin C, Lin SW, Weng SF, Lin YS.

Head Neck. 2014 Feb;36(2):203-8. doi: 10.1002/hed.23278. Epub 2013 Jun 18.

PMID:
23780872
16.

Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma.

Chang C, Middeldorp J, Yu KJ, Juwana H, Hsu WL, Lou PJ, Wang CP, Chen JY, Liu MY, Pfeiffer RM, Chen CJ, Hildesheim A.

J Med Virol. 2013 Mar;85(3):524-9. doi: 10.1002/jmv.23498. Epub 2012 Dec 21.

17.

Interval cancers in nasopharyngeal carcinoma screening: comparing two screening intervals after a negative initial screening result.

Chen F, Huang QH, Fang F, Liu ZW, Liu K, Xie SH, Liu Q, Hong MH, Liao ZE, Ye WM, Zeng YX, Cao SM.

J Med Screen. 2012 Dec;19(4):195-200. doi: 10.1258/jms.2012.012068. Epub 2012 Dec 20.

PMID:
23258840
18.

Liu et al. respond to "Epstein-Barr virus screening for nasopharyngeal carcinoma".

Liu Z, Ye W, Zeng YX, Cao SM.

Am J Epidemiol. 2013 Feb 1;177(3):254-5. doi: 10.1093/aje/kws405. Epub 2012 Dec 19. No abstract available.

19.

Invited commentary: Epstein-Barr virus-based screening for the early detection of nasopharyngeal carcinoma: a new frontier.

Hildesheim A.

Am J Epidemiol. 2013 Feb 1;177(3):251-3. doi: 10.1093/aje/kws403. Epub 2012 Dec 19.

20.

Nasopharyngeal carcinoma -- analysis of risk factors and immunological markers.

Anghel I, Anghel AG, Dumitru M, Soreanu CC.

Chirurgia (Bucur). 2012 Sep-Oct;107(5):640-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk